Alsina L, Montoro B, Moral P, Neth O, Ortiz M, Sánchez-Ramón S, Presa M, Oyagüez I, Casado MA, González-Granado I
Cost Analysis of IV and SC immunoglobulins used in the treatment of primary immunodeficiency disease in Spain
2019 Meeting of the European Society for Inmunodeficiencies (ESID). Bruselas (Bélgica). 18-21 sep 2019
Massuti T, Lázaro M, Isla D, Ruiz de Alda L, Gordo R, Ortega-Joaquín N, Oyagüez I
A Cost Analysis of the management of CNS metastases in patients with advanced ALK+NSCLC: alectinib vs crizotinib
20th World Conference on Lung Cancer (IASLC).Barcelona. 7-10 sep 2019
Ruiz-Moreno JM, de Andrés-Nogales F, Oyagüez I, Ruiz-Medrano J
Cost-consequence Analysis of Extended Loading Dose from 3 to 6 months of Anti VEGF Treatment In Diabetic Macular Edema Patients
Euretina Congress. Paris (France). 5-8 sep 2019
Burgos-Pol R, Barrios V, Cinza-Sanjurjo S, Gavín O, Egocheaga I, Soto J, Polanco C, Suarez J, Casado MA
Cost and burden of poor control of the level of anticoagulation in patients with non-valvular atrial fibrillation treated with vitamin K antagonist in the Spanish National Health Service
European Society of Cardiology Congress. Paris (France). 31 ago-04 sep 2019
Soto J, Casado MA
La trayectoria metodológica de la evaluación de la eficiencia y su futuro
Papeles de Economía Española 2019; 160: 156-164
Oyagüez I, Suárez C, López-Sendón JL, González-Juanatey JR, de Andrés-Nogales F, Suarez J, Polanco C, Soto J